Skip to content

AquaHumana – Quantitative Tissue Water Determination with Spectral Data – Feasibility Study

AquaHumana – Quantitative Tissue Water Determination with Spectral Data – Feasibility Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034661
Enrollment
20
Registered
2025-04-07
Start date
2024-09-24
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E87.7 E86

Interventions

Group 1: Objective of the Study The aim of this clinical study is to evaluate a new measurement method that uses spectral data to determine tissue water content in patients. This method involves the t

Sponsors

Universitätsklinikum Ulm/Institut für Geriatrische Forschung c/o AGAPLESION Bethesda Klinik Ulm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with edema or clinical hyperhydration, e.g., patients with right-sided cardiac decompensation (clinically assessed by medical personnel) - Patients with dehydration (clinically assessed by medical personnel)

Exclusion criteria

Exclusion criteria: - Patients unable to give consent (e.g. known advanced dementia) - Limited communication ability (e.g. due to lack of language proficiency) - Patients in palliative care (life expectancy <3 months based on clinical assessment by medical personnel)

Design outcomes

Primary

MeasureTime frame
T0-T6 (3x daily, morning, midday, evening) total body water content (%) determined by spectral measurement T0-T6 (morning): Clinical assessment of fluid balance T0, T3,T6, (morning): Laboratory analysis of serum osmolality T0, T3, T6 (morning): quantitative measurement of saliva osmolality T0, T3,T6, (morning ):Sonographic evaluation of intravascular volume status (width of the V. cava, respiratory variability) T0, T3,T6, (morning ): Determination of body composition using bioelectrical impedance analysis (BIA)

Secondary

MeasureTime frame
wearing comfort of the sensor

Countries

Germany

Contacts

Public ContactMichael Denkinger

Institut für Geriatrische Forschung/ AGAPLESION Bethesda Klinik Ulm

michael.denkinger@agaplesion.de0731 187 433

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026